Director, International Market Access BBU & OBU

Introduction to role:Are you ready to develop access strategies that turn a remarkable pipeline into real patient impact throughout MEA, Asia, and LATAM? Based in Dubai, UAE, you will lead pricing, reimbursement, and value strategy execution across International Markets for our Oncology and Biopharmaceutical portfolios, accelerating timely and balanced access where it matters most. You will connect global, regional, and local teams to co-create compelling value propositions, launch sequencing, and access scenarios for wave 1 markets, ensuring our science is matched by adoption and affordability. How would you elevate affiliate capabilities and secure swift reimbursement across diverse payer systems while navigating evolving policies and funding models? Working across the full patient journey—from screening to treatment—you will bring together evidence, policy, and commercial insights to influence payers, align stakeholders, and remove barriers to access. Your leadership will simplify pricing governance, build regional capabilities, and set the standard on launch excellence. We are recruiting for three positions through this single advertisement, with opportunities available across both OBU and BBU. Candidates only need to submit one application to be considered for the relevant roles. Accountabilities • International Critical Initiatives: Drive International AI substantiation tools in line with International AI30 goals; pioneer innovative access approaches to enhance patient reach across diverse market archetypes, especially for new assets; advise and collaborate with OMAP/GMAP and Global Governmental Affairs on strategic payer policy shaping; strengthen Marketing Company capabilities and share standards across the region • Market Access Strategy and Execution: Co-develop and assist in implementation of integrated market access strategies across International Markets aligned with global and regional priorities across BBU (R&I, CVRM, V&I) and OBU; lead planning for pipeline and in-line products with a focus on priority markets to secure strong reimbursement and pricing outcomes; support affiliates navigating payer, HTA, and reimbursement environments; identify risks and opportunities amid geopolitical shifts (e.g., MFN, alternative funding models) to protect wave 1 launch ambition • Capability Building: Develop and implement market access capability-building initiatives for the Middle East, Asia-Pacific, and Latin American regions. Create frameworks, tools, training programs, and protocols to improve affiliate excellence. Coach and mentor regional and local market access teams to prepare for wave 1 launch. Encourage a culture of continuous learning and knowledge sharing • Pricing and Financial Process Simplification: Lead simplification and optimization of pricing governance and financial processes, including interactions with GPI and PRICE cases; drive consistency and clarity in pricing approval workflows, contracting approaches, and financial evaluations; collaborate with finance and commercial teams to streamline case development and approvals; ensure strategies align with corporate objectives, compliance requirements, and business cycles (MTP, RBU, QBR) • Case Development and Launch Strategy: Co-develop and assess pricing and reimbursement cases for new launches and lifecycle initiatives with focus on Baxfendy, Tozo, and ONC priorities; provide strategic feedback on pricing corridors, launch sequencing, and access scenarios to ensure launch feasibility and viability; partner with global and regional collaborators to evaluate financial impact, profitability, and access trade-offs, leading completion of ILVA and IRex; support evidence-based decisions via market insights and competitive intelligence • Launch Readiness: Lead and evaluate launch readiness activities for assigned markets and support LRRs. Ensure affiliates have pricing, reimbursement, partner engagement, evidence generation, and access plans. Act as the direct link to GMAP/OMAP and global product teams. Establish readiness frameworks, achievements, and governance. Coordinate progress and overcome hindrances to timely patient access • Value Development and Evidence Generation: Collaborate with medical, HEOR, and commercial teams on evidence generation strategies. Ensure RWE and evidence needs for priority markets are captured in the Coordinated Medical Evidence Plan. Support adaptation of global value dossiers for local reimbursement requirements by leveraging the Health Economics Centre of Excellence in GMAP/OMAP • Cross-Functional and External Collaboration: Work closely with medical affairs, regulatory, commercial, finance, and supply chain teams. Build positive relationships with regional affiliates and external partners when appropriate. Support long-term planning and portfolio prioritization. Ensure alignment between regional execution and global direction to deliver balanced patient access and growth Essential Skills/Experience • Bachelor’s degree or equivalent experience required; advanced degree in Life Sciences, Pharmacy, Health Economics, Business, or related field preferred • Significant experience in pharmaceutical or biotechnology market access, pricing, reimbursement, or health policy roles • Proven international experience across emerging and developed healthcare markets, particularly within MEA, Asia, and LATAM • Strong understanding of HTA, payer systems, reimbursement frameworks, and pricing dynamics • Proven experience leading cross-functional and multicultural teams • Strong financial competence and experience developing pricing and reimbursement cases • Critical thinking and problem solving • Strong leadership and influencing skills • Cross-cultural collaboration and partner management • Financial and analytical savvy • Change management and process simplification • Excellent communication and presentation skills • Project and launch management expertise - Ability to operate effectively in complex matrix organizations Desirable Skills / Experience • Experience supporting global or regional product launches preferred Why AstraZeneca Join a team where market access expertise directly translates powerful science into real-world availability across diverse health systems. You will collaborate with unexpected combinations of experts—medical, HEOR, policy, finance—often gathered around the same table to turn evidence into bold access strategies. Seize this opportunity to lead launches, simplify access, and build capabilities that bring life-changing medicines to patients across MEA, Asia, and LATAM. Date Posted 02-Sep-2026 Closing Date 10-Sep-2026 AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

Bachelor’s degree or equivalent experience required; advanced degree in Life Sciences, Pharmacy, Health Economics, Business, or related field preferred. Significant experience in pharmaceutical or biotechnology market access, pricing, reimbursement, or health policy roles. Proven international experience across emerging and developed healthcare markets, particularly within MEA, Asia, and LATAM. Strong understanding of HTA, payer systems, reimbursement frameworks, and pricing dynamics. Proven experience leading cross-functional and multicultural teams. Strong financial competence and experience developing pricing and reimbursement cases. Critical thinking and problem solving. Strong leadership and influencing skills. Cross-cultural collaboration and partner management. Financial and analytical savvy. Change management and process simplification. Excellent communication and presentation skills. Project and launch management expertise with the ability to operate effectively in complex matrix organizations.

International Critical Initiatives: Drive International AI substantiation tools in line with International AI30 goals; pioneer innovative access approaches to enhance patient reach across diverse market archetypes, especially for new assets; advise and collaborate with OMAP/GMAP and Global Governmental Affairs on strategic payer policy shaping; strengthen Marketing Company capabilities and share standards across the region. Market Access Strategy and Execution: Co-develop and assist in implementation of integrated market access strategies across International Markets aligned with global and regional priorities across BBU (R&I, CVRM, V&I) and OBU; lead planning for pipeline and in-line products with a focus on priority markets to secure strong reimbursement and pricing outcomes; support affiliates navigating payer, HTA, and reimbursement environments; identify risks and opportunities amid geopolitical shifts (e.g., MFN, alternative funding models) to protect wave 1 launch ambition. Capability Building: Develop and implement market access capability-building initiatives for the Middle East, Asia-Pacific, and Latin American regions. Create frameworks, tools, training programs, and protocols to improve affiliate excellence. Coach and mentor regional and local market access teams to prepare for wave 1 launch. Encourage a culture of continuous learning and knowledge sharing. Pricing and Financial Process Simplification: Lead simplification and optimization of pricing governance and financial processes, including interactions with GPI and PRICE cases; drive consistency and clarity in pricing approval workflows, contracting approaches, and financial evaluations; collaborate with finance and commercial teams to streamline case development and approvals; ensure strategies align with corporate objectives, compliance requirements, and business cycles (MTP, RBU, QBR). Case Development and Launch Strategy: Co-develop and assess pricing and reimbursement cases for new launches and lifecycle initiatives with focus on Baxfendy, Tozo, and ONC priorities; provide strategic feedback on pricing corridors, launch sequencing, and access scenarios to ensure launch feasibility and viability; partner with global and regional collaborators to evaluate financial impact, profitability, and access trade-offs, leading completion of ILVA and IRex; support evidence-based decisions via market insights and competitive intelligence. Launch Readiness: Lead and evaluate launch readiness activities for assigned markets and support LRRs. Ensure affiliates have pricing, reimbursement, partner engagement, evidence generation, and access plans. Act as the direct link to GMAP/OMAP and global product teams. Establish readiness frameworks, achievements, and governance. Coordinate progress and overcome hindrances to timely patient access. Value Development and Evidence Generation: Collaborate with medical, HEOR, and commercial teams on evidence generation strategies. Ensure RWE and evidence needs for priority markets are captured in the Coordinated Medical Evidence Plan. Support adaptation of global value dossiers for local reimbursement requirements by leveraging the Health Economics Centre of Excellence in GMAP/OMAP. Cross-Functional and External Collaboration: Work closely with medical affairs, regulatory, commercial, finance, and supply chain teams. Build positive relationships with regional affiliates and external partners when appropriate. Support long-term planning and portfolio prioritization. Ensure alignment between regional execution and global direction to deliver balanced patient access and growth.